After waiting for a long time, Kenyans who had taken the first dose of Covid-19 Vaccine now need not to worry anymore since the Ministry of Health has announced good news. This is after the MOH announced that second dose of AstraZeneca Covid vaccine will be administered next week.
This comes at a time when the country is at a risk of facing another wave of the pandemic. Additionally, leaders in the counties of Lake Victoria Region have warned that the current situation may continue to worsen in the region if action is not taken. The leaders warn that the region is staring to a possible lockdown if the infections continue rising.
More details emerges illustrating that those who have never receive any dose of the Covid-19 vaccine will be administered with Johnson & Johnson jab. The J&J vaccine is usually a single-dose vaccine while AstraZeneca is a two-dose vaccine. It therefore means that those who will receive Johnson & Johnson jab will receive it only once.
In addition to this, Kenya will also receive 24 million doses of AstraZeneca which will cost Sh389 million. This will be achieved via COVAX facility. Kenya will also procure another 10 million doses of Covid-19 Vaccine.
The ministry of health will therefore receive enough doses to ensure that each Kenyan has a chance of getting the jab. However the ministry of health will first begin by administering the vaccine to those who had received the first jab and ensuring that every health care worker has been vaccinated. This will be followed by full vaccination of all teachers before proceeding to the rest of the population.
MOH cited that the inequalities in access as well as availability of the AstraZeneca Covid-19 vaccine is due to the current worse situation in India. It was explained that the AstraZeneca shortage was created by the rise in cases of infection in India which called for emergency.